Company Alpha Cognition Inc. Toronto S.E.
Equities
ACOG
CA02074J2048
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -.--% | -.--% |
04/04 | Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period | MT |
04/04 | Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Denis G. Kay
FOU | Founder | - | 01/00/01 |
Michael McFadden
CEO | Chief Executive Officer | 57 | 12/21/12 |
Ken Cawkell
FOU | Founder | 72 | 01/20/01 |
Donald Kalkofen
DFI | Director of Finance/CFO | 60 | 12/22/12 |
Lauren DAngelo
COO | Chief Operating Officer | - | 04/21/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Cawkell
FOU | Founder | 72 | 01/20/01 |
Rajeev Bakshi
BRD | Director/Board Member | 64 | 22/21/22 |
Michael McFadden
CEO | Chief Executive Officer | 57 | 12/21/12 |
Len Mertz
CHM | Chairman | - | 22/21/22 |
Phillip Mertz
BRD | Director/Board Member | - | 22/21/22 |
John Havens
BRD | Director/Board Member | - | 22/21/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 150,225,536 | 118,323,040 ( 78.76 %) | 0 | 78.76 % |
Stock B | 0 | 7,916,380 | 0 | 0 |
Company contact information
Alpha Cognition, Inc.
750 West Pender Street Suite 1200
V6C 2T8, Vancouver
+
http://www.alphacognition.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- ACOG Stock
- ACOG Stock
- Company Alpha Cognition Inc.